Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2007
11/14/2007EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/14/2007EP1854487A2 Combinations of an 11-beta-hydroxysteroid dehaydrogenase type 1 inhibitor and a glucocorticoid receptor agonist
11/14/2007EP1854486A2 Utilisation of neurotransmitter derivatives for manufacturing agents for treating neuroendocrinal diseases
11/14/2007EP1854485A1 Preventives/remedies for cancer
11/14/2007EP1854484A1 Pain remedy containing rock inhibitor
11/14/2007EP1854483A1 Agent for control of function of antigen-presenting cell
11/14/2007EP1854482A1 Agent for control of degranulation reaction and cytokine production
11/14/2007EP1854481A2 Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1854466A1 Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
11/14/2007EP1854464A2 Combinations comprising epothilone derivatives
11/14/2007EP1854454A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
11/14/2007EP1853349A1 Composition for treating mental health disorders
11/14/2007EP1853317A2 Compositions and methods for treating or preventing flaviviridae infections
11/14/2007EP1853316A1 Use of an antagonist of epac for treating human cardiac hypertrophy
11/14/2007EP1853315A1 Treatment for mucositis
11/14/2007EP1853270A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853220A1 Production process for nsaid-containing lozenges, their compositions, their medicinal use
11/14/2007EP1696909B1 Benzothiazole derivatives for the treatment of diabetes
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1399423B1 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
11/14/2007EP1370264B1 Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases
11/14/2007EP1317238B1 Compositions containing a vitamin c component and pigment
11/14/2007EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1141079B1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1102593B1 Prostate formula
11/14/2007EP1091735B1 Improved enriched platelet wound healant
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN101069746A Composition containing sugar-reducing medicine and antiplatelet medicine
11/14/2007CN101069745A Sugar-reducing medicine composition
11/14/2007CN101069685A Solid drug for oral use
11/14/2007CN101069684A Composition comprising a cholesterol absorption inhibitor, and hmg-coa reductase inhibitor and a stabilizing agent
11/14/2007CN101069660A Biliary-tract carriage carrying about medicine and preparing method therefor
11/14/2007CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
11/14/2007CN100348265C Controlled release composition and method of producing the same
11/14/2007CN100348183C Medium chain fatty acids applicable as anitmicrobial agents
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294651 Inhibition of exoprotein production using isoprenoid compositions
11/13/2007US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294476 Testing a compound for the ability to inhibit PKG I alpha; testing the compound for the ability to inhibit PKG I beta; identifying the compound as a candidate drug useful in the treatment of pain ifit selectively inhibits PKG I alpha relative to PKG I beta .
11/13/2007US7294455 Fixed-dried platelets cross-linked to protein
11/13/2007US7294339 Method for treating allodynia by peripheral administration of a neurotoxin
11/13/2007US7294337 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies
11/13/2007US7294334 Methods and compositions to treat myocardial conditions
11/13/2007US7294332 Combination therapy (temozolomide and α-IFN) for advanced cancer
11/13/2007CA2431586C Antibiotic/benzoyl peroxide dispenser
11/13/2007CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof
11/13/2007CA2396159C Novel substituted benzimidazole dosage forms and method of using same
11/13/2007CA2383715C Improving condition of elderly pets
11/13/2007CA2292965C Pyrrolidine derivative hair growth compositions and uses
11/13/2007CA2285574C Method and composition for treating sleep apnea
11/13/2007CA2253257C Receptor for underivatized, aqueous soluble .beta.(1-3)-glucan
11/08/2007WO2007127667A1 Augmentation of titer for vaccination in animals
11/08/2007WO2007127377A2 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease
11/08/2007WO2007126455A2 Method for using boc/cdo to modulate hedgehog signaling
11/08/2007WO2007126126A1 Novel aminopyridine derivative having aurora-a-selective inhibitory activity
11/08/2007WO2007126104A1 Method of predicting skin spot formation and method of screening skin spot formation inhibitor with the use of spot site-increasing genes as indication
11/08/2007WO2007125883A1 Composition for improvement in sleep quality
11/08/2007WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet
11/08/2007WO2007125310A2 Pharmaceutical combinations of pk inhibitors and other active agents
11/08/2007WO2007103427A3 Medical use of bilirubin and its structural analogues
11/08/2007WO2007096601A3 Antimicrobial formulations comprising a quinone and a copper salt
11/08/2007WO2007092590A3 Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa)
11/08/2007WO2007072221A3 Surface marker-directed cancer therapeutics
11/08/2007WO2006120360A3 Active composition for treatment or prevention of problems related to a disturbance of the biological clock
11/08/2007WO2006085983A3 Viral adjuvants
11/08/2007US20070259890 Compounds and Compositions as Ppar Modulators
11/08/2007US20070259824 identifying a substance that down-regulates an immune response in an animal, comprising determining whether substance inhibits an interaction between factors in the CD26 signaling pathway, wherein substance inhibits the interaction between CD26 and caveolin-1
11/08/2007US20070259813 Anti-Bacterial Composition Especially for Controlling Gram-Negative Bacteria, Comprising a Peptide and an Advantageously Hydrophobic Anti-Bacterial Agent
11/08/2007US20070259811 Method of modulating the proliferation of medullary thyroid carcinoma cells
11/08/2007US20070259400 Antibodies
11/08/2007US20070259378 For drug screening; competitive binding; measuring activation by measuring [Ca2+] in the mixture
11/08/2007US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/08/2007US20070259050 Combined Cosmetic or Therapeutic Preparation
11/08/2007US20070259007 Lactoferrin: an adjuvant for vaccines
11/08/2007US20070258991 Immunogenic agent therapy using plasmapheresis
11/08/2007US20070258984 Anti-neoplastic composition of 5-FU, leucovorin, irinotecan, oxaliplatin, capecitabine, paclitaxel or doxetaxel; breast cancer, colorectal cancer, rectal cancer, non-small cell lung cancer, non-Hodgkins lymphoma (NHL), renal cell cancer, prostate cancer, liver cancer
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand
11/08/2007US20070258961 Cholesterol efflux and uses thereof
11/08/2007US20070258960 Stabilized products, process and devices for preparing same
11/08/2007US20070258958 Interactive wound cover
11/08/2007US20070258951 Methods of treating cardiac disorders
11/08/2007US20070258943 Genetically engineered cells for therapeutic applications
11/08/2007DE102006020604A1 Flüssige Arzneimittelformulierung Liquid pharmaceutical formulation
11/08/2007CA2650775A1 Modified metallothioneins and methods for screening and treatment of diseases associated with oxidative stress
11/08/2007CA2650607A1 Compositions and methods for the treatment of cardiovascular disease
11/08/2007CA2650572A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
11/08/2007CA2650341A1 Augmentation of titer for vaccination in animals
11/08/2007CA2647939A1 Methods and compositions for vaccination of poultry
11/08/2007CA2647277A1 Method for using boc/cdo to modulate hedgehog signaling